Apellis Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.09.24	Apellis Says CHMP Confirms Negative Opinion For Pegcetacoplan In Geographic Atrophy, Stock Down (RTTNews)
08.08.24	Apellis Pharma Phase 3 VALIANT Study Of Pegcetacoplan Meets Primary Goal; Stock Up In Pre-market (RTTNews)
26.01.24	Apellis: EU's CHMP Adopts Negative Opinion For Pegcetacoplan For GA; To Seek Re-Examination Of MAA (RTTNews)
14.12.23	Apellis Pharma Sinks On Indication Of CHMP's Negative Opinion On Pegcetacoplan (RTTNews)
06.10.23	Pre-market Movers: COCH, TAOP, BEEP, NBTX, PXD… (RTTNews)
02.10.23	Apellis Pharmaceuticals Announces FDA Approval Of EMPAVELI Injector - Quick Facts (RTTNews)
24.09.23	APLS NOTICE: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 2 Deadline in Securities Class Action - APLS (PR Newswire)
16.09.23	ROSEN, LEADING INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
09.09.23	ROSEN, LEADING INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
02.09.23	ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
25.08.23	ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
18.08.23	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
10.08.23	ROSEN, A TOP RANKED LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APLS (PR Newswire)
04.08.23	ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - APLS (PR Newswire)
27.07.23	APLS LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - APLS (PR Newswire)
21.07.23	Apellis Investigation Notification: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Investors (PR Newswire)
03.04.23	Pre-market Movers: INDO, GFAI, APLM, UHG, HUSA… (RTTNews)
21.02.23	Pre-market Movers: ARBE, SGML, ATNM, BTCS, OKYO… (RTTNews)
18.02.23	FDA Approves Apellis' Syfovre For Geographic Atrophy Treatment (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)
16.12.22	Apellis Pharma Submits MAA To European Medicines Agency For Intravitreal Pegcetacoplan (RTTNews)
18.11.22	Apellis : FDA Accepts Pegcetacoplan NDA Amendment For Geographic Atrophy; Stock Up (RTTNews)
26.10.22	Biotech Stocks Facing FDA Decision In November 2022 (RTTNews)
05.05.22	ABC Boosts EPS Outlook, ADPT Sees 20-26% Revenue Growth, ANAB To Report HARP Data In Q3 (RTTNews)
24.03.22	Pre-market Movers: MFH, ESOA, COOK, FSRD, ALLG… (RTTNews)
28.05.20	Apellis Pharma Initiates Phase 1/2 Study Of APL-9 In Patients With COVID-19 (RTTNews)
08.01.20	APLS Soars On PNH Data, ADXS On Track, TYME In Deal With Eagle, CVM On Watch (RTTNews)
22.08.19	Apellis Pharma : Scaling New Highs (RTTNews)
16.06.19	Apellis Pharmaceuticals präsentiert Daten aus der laufenden APL-2 Phase-2-Studie bei Patienten mit Kälteagglutininkrankheit und warmer autoimmun-hämolytischer Anämie beim 24, Kongress der European Hem (GlobeNewswire)
15.06.19	Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (E (GlobeNewswire)
01.02.19	UPDATE - Apellis Pharmaceuticals ernennt Thomas Lackner zum Senior Vice President, Head of Europe (GlobeNewswire)
01.02.19	Apellis Pharmaceuticals ernennt Thomas Lackner zum Senior Vice President, Head of Europe (GlobeNewswire)
31.01.19	Apellis Pharmaceuticals Appoints Thomas Lackner as Senior Vice President, Head of Europe (GlobeNewswire)
03.12.18	XLRN On Watch, BPMC Makes An Imprint, Osteoporosis Drug Evenity Faces FDA Panel (RTTNews)
19.10.18	EARS Tumbles, APLS Pauses Dosing, PTE Plunges On Short-seller Report Again (RTTNews)
01.08.18	APLS To Report Data In 2H, CUR Abuzz, Shire Discontinues NASH Trial (RTTNews)
01.05.18	INGN Soars On Revised Outlook, MRK Faces FDA In Sep., KPTI Taken By STORM (RTTNews)
17.04.18	APVO Walks The Talk, Eleven Bio Gains Over 13%, PADDOCK Data Boosts APLS (RTTNews)
12.04.18	In The Spotlight: Apellis Pharma (RTTNews)
20.03.18	ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch (RTTNews)
15.03.18	DXR Soars On Big Volume, RXII Gets Attention, Busy Q2 Awaits SNDX (RTTNews)
27.02.18	ZSAN Explodes, TTPH On Radar, APLS Catches Eyes, CERC Hits A High (RTTNews)
31.01.18	KZIA Up 68% In 5 Days, APLS Bouncing Back, AKAO Clears A Hurdle, MDGL Abuzz (RTTNews)
18.01.18	JUNO Flies On Takeover Rumor, PRTO For Long Haul, SUPN Gaining Strength (RTTNews)
11.01.18	D-Day For ARDM Today, ALRN To Report Data In 1H18, DFFN On Watch (RTTNews)
04.01.18	ARWR Hits A High, URGN Begins 2018 In Style, ARNA To Report Data In Q1 (RTTNews)
22.12.17	APLS Sets Out Its Vision, APEN Gains Weight, Packed Year Ahead For DRNA (RTTNews)
19.12.17	LENS Comes Into Focus, MESO, TIG Ink Deal, NBRV Leaps Forward (RTTNews)
13.12.17	Busy Year Ahead For OMED, There's HOPE For GBT, APLS Sinks Below IPO Price (RTTNews)
07.12.17	Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards Lifesciences (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Apellis Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten